Φορτώνει......
Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis
[Image: see text] Multiple effects on cancer cells are exerted by the peroxisome proliferator-activated receptor γ (PPAR-γ). Recent studies have shown that rosiglitazone, a synthetic PPAR-γ ligand, inhibits the growth of cells. This research was designed to assess the impact of rosiglitazone on diet...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | ACS Omega |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Chemical Society
2020
|
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7081392/ https://ncbi.nlm.nih.gov/pubmed/32201822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b04357 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|